Cargando…

Do antibodies enhance the infection of cells by HIV?

Detalles Bibliográficos
Autor principal:	Bolognesi, Dani P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095050/ https://www.ncbi.nlm.nih.gov/pubmed/2787895 http://dx.doi.org/10.1038/340431a0

Ejemplares similares

Identification of HIV gp41-specific antibodies that mediate killing of infected cells
por: Williams, Katherine L., et al.
Publicado: (2019)

Complement supports progression of HIV and turns neutralising antibodies at low concentration into infection enhancing antibodies
por: Dierich, Manfred P, et al.
Publicado: (2006)

To do or not to do; that is the question!
por: Dani, Nitin
Publicado: (2018)

Traitors of the immune system—Enhancing antibodies in HIV infection: Their possible implication in HIV vaccine development
por: Beck, Zoltán, et al.
Publicado: (2008)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
por: Dupuy, Franck P., et al.
Publicado: (2019)

Neutralization and enhancement of trans infection by erythrocyte-bound HIV with antibodies and complement
por: Beck, Z, et al.
Publicado: (2012)

Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
por: Boutin, Marianne, et al.
Publicado: (2022)

Mother–Infant HIV Transmission: Do Maternal HIV-Specific Antibodies Protect the Infant?
por: Overbaugh, Julie
Publicado: (2014)

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections
por: Promsote, Wanwisa, et al.
Publicado: (2023)

CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection
por: Veenhuis, Rebecca T., et al.
Publicado: (2021)

Across Functional Boundaries: Making Nonneutralizing Antibodies To Neutralize HIV-1 and Mediate Fc-Mediated Effector Killing of Infected Cells
por: Richard, Jonathan, et al.
Publicado: (2021)

Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Bruel, Timothée, et al.
Publicado: (2016)

Neutralizing Antibodies Inhibit HIV-1 Infection of Plasmacytoid Dendritic Cells by an FcγRIIa Independent Mechanism and Do Not Diminish Cytokines Production
por: Lederle, Alexandre, et al.
Publicado: (2014)

Neutralization-Enhancing RF Antibodies for HIV Vaccines
por: Suslov, Konstantin V.
Publicado: (2014)

Mining HIV controllers for broad and functional antibodies to recognize and eliminate HIV-infected cells
por: Rossignol, Evan D., et al.
Publicado: (2021)

Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
por: Gunn, Bronwyn, et al.
Publicado: (2016)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not facilitate antibody-dependent enhance of viral infection.
por: Clark, Natasha M, et al.
Publicado: (2021)

Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies
por: Pham, Tram N. Q., et al.
Publicado: (2016)

Antibody-Dependent Enhancement of Viral Infections
por: Kulkarni, Ruta
Publicado: (2019)

Effect of HIV Envelope Vaccination on the Subsequent Antibody Response to HIV Infection
por: Ditse, Zanele, et al.
Publicado: (2020)

Immune checkpoint modulation enhances HIV-1 antibody induction
por: Bradley, Todd, et al.
Publicado: (2020)

Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing
por: Mathur, Shubham, et al.
Publicado: (2022)

Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals
por: Kant, Sanket, et al.
Publicado: (2019)

Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection
por: Spindler, J., et al.
Publicado: (2011)

Neutralizing Antibody-Based Prevention of Cell-Associated HIV-1 Infection
por: Parsons, Matthew S, et al.
Publicado: (2018)

Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
por: Willey, Suzanne, et al.
Publicado: (2011)

Anti-SARS-CoV-2 IgG and IgA antibodies in COVID-19 convalescent plasma do not enhance viral infection
por: Clark, Natasha M., et al.
Publicado: (2022)

Antibody Maturation and Viral Diversification in HIV-Infected Women
por: James, Maria M., et al.
Publicado: (2013)

Antibody-Dependent Enhancement: ″Evil″ Antibodies Favorable for Viral Infections
por: Yang, Xiaoke, et al.
Publicado: (2022)

Polyreactive Antibodies Plus Complement Enhance the Phagocytosis of Cells Made Apoptotic by UV-Light or HIV
por: Zhou, Zhao-hua, et al.
Publicado: (2013)

What Do Antibody Studies Tell Us about Viral Infections?
por: Ilinykh, Philipp A., et al.
Publicado: (2022)

Natural Killer Cells in Antibody Independent and Antibody Dependent HIV Control
por: Bernard, Nicole F., et al.
Publicado: (2022)

Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy
por: Spaan, Michelle, et al.
Publicado: (2016)

Regulatory T Cells in Arterivirus and Coronavirus Infections: Do They Protect Against Disease or Enhance it?
por: Cecere, Thomas E., et al.
Publicado: (2012)

Importance of an Early HIV Antibody Differentiation Immunoassay for Detection of Dual Infection with HIV-1 and HIV-2
por: Zbinden, Andrea, et al.
Publicado: (2016)

HIV-1 neutralizing antibodies provide sterilizing immunity by blocking infection of the first cells
por: Stab, Viktoria, et al.
Publicado: (2023)

Antibody-mediated prevention and treatment of HIV-1 infection
por: Gruell, Henning, et al.
Publicado: (2018)

A novel trifunctional IgG-like bispecific antibody to inhibit HIV-1 infection and enhance lysis of HIV by targeting activation of complement
por: Jia, Leili, et al.
Publicado: (2010)

Antibody‐virus co‐evolution in HIV infection: paths for HIV vaccine development
por: Bonsignori, Mattia, et al.
Publicado: (2017)

Strategies for enhancing CAR T cell expansion and persistence in HIV infection
por: Rothemejer, Frederik Holm, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p8lihe0sj7uu3jgiv4tpe9n2jf